Learning Objectives:

At the completion of this course, the participant should be able to:

• Evaluate ceftobiprole's effectiveness in treating complicated staphlococcus aureus bacteremia.
• Review results of ERADICATE, a phase 3 trial comparing ceftobiprole with daptomycin in patients who had complicated S. aureus bacteremia.

Speaker:

Alison Brodginski, DO, Staff, Geisinger - has nothing to disclose.